Table 3. Anti-A/B antibody or HLA-DSA status at the time of antibody mediated rejection.
| Donor Recipient Blood type | Anti-A/B Antibody | HLA-DSA | ||
|---|---|---|---|---|
| ABOi | Case 1 | A → O | Anti-A IgG > 1:1024 | (-) |
| Case 2 | B → O | Anti-B IgG: 1:128 | (-) | |
| ABOi+HLAs | Case 3 | AB → O | Anti-A IgG; 1:16, Anti-B IgG; 1:8 | DR01, DR07 |
| Case 4 | B → O | Anti-B IgG; Negative | A02, DR08 | |
| Case 5 | A → B | Anti-A IgG; Negative | DR09 | |
| Case 6 | AB → A | Anti-B IgG < 1:4 | DR08 | |
| HLAs | Case 7 | AB → AB | N/A | (-) |
| Case 8 | B → B | N/A | (-) | |
| Case 9 | B → B | N/A | A11 | |
| Case 10 | O → AB | N/A | A29 | |
| Case 11 | A → A | N/A | DR10 | |
| Case 12 | A → A | N/A | DR09 | |
| Case 13 | O → O | N/A | B51 | |
| CONT | Case 14 | A →A | N/A | (-) |
| Case 15 | B →B | N/A | DR08 | |
| Case 16 | O →O | N/A | DR53 |
ABOi, ABO incompatible; HLAs, sensitized to HLA; HLA-DSA, donor-specific anti-HLA antibody; CONT, control; N/A, non-applicable